Gilead shareholders approve 2022 Equity Incentive Plan, elect directors, reject most proposals

GILEAD SCIENCES, INC.

Elected 9 directors; CEO O'Day received 871.8M votes for (87.2%) and 71.4M against.
Ratified Ernst & Young as auditor for FY2022: 1.02B for, 60.6M against.
Advisory approval of executive compensation: 875.8M for, 74.4M against, 2.2M abstentions.
Approved 2022 Equity Incentive Plan authorizing up to 132M shares: 864.6M for, 85.9M against.
Shareholder proposal for special meeting with 10% threshold passed (52.2% for); independent chair, labor rep, lobbying review, anticompetitive oversight proposals failed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.